Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of MEDICAMEN BI. For more details, see the MEDICAMEN BI quarterly results and MEDICAMEN BI share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.3 |
No. of shares | m | 12.71 |
1 Week | % | -2.1 |
1 Month | % | 4.1 |
1 Year | % | -41.9 |
52 week H/L | Rs | 903.5/356.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
MEDICAMEN BI EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 709 | 556 | 665 | 1,023 | 1,219 | |
Low | Rs | 390 | 153 | 177 | 460 | 559 | |
Sales per share (Unadj.) | Rs | 104.8 | 102.7 | 92.2 | 94.5 | 111.4 | |
Earnings per share (Unadj.) | Rs | 10.3 | 10.9 | 9.9 | 12.2 | 11.6 | |
Diluted earnings per share | Rs | 9.5 | 10.5 | 9.5 | 11.7 | 11.6 | |
Cash flow per share (Unadj.) | Rs | 12.2 | 12.9 | 12.0 | 16.9 | 16.7 | |
Dividends per share (Unadj.) | Rs | 1.00 | 0.50 | 1.00 | 1.00 | 1.00 | |
Adj. dividends per share | Rs | 0.92 | 0.48 | 0.96 | 0.96 | 0.99 | |
Avg Dividend yield | % | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | |
Book value per share (Unadj.) | Rs | 74.0 | 99.2 | 108.7 | 119.9 | 152.8 | |
Adj. book value per share | Rs | 68.1 | 95.3 | 104.5 | 115.2 | 152.0 | |
Shares outstanding (eoy) | m | 11.70 | 12.22 | 12.22 | 12.22 | 12.65 | |
Price / Sales ratio | x | 5.2 | 3.5 | 4.6 | 7.8 | 8.0 | |
Avg P/E ratio | x | 53.5 | 32.6 | 42.4 | 60.8 | 76.4 | |
P/CF ratio (eoy) | x | 45.1 | 27.4 | 35.1 | 43.8 | 53.3 | |
Price / Book Value ratio | x | 7.4 | 3.6 | 3.9 | 6.2 | 5.8 | |
Dividend payout | % | 9.7 | 4.6 | 10.1 | 8.2 | 8.6 | |
Avg Mkt Cap | Rs m | 6,429 | 4,331 | 5,144 | 9,060 | 11,246 | |
Total wages/salary | Rs m | 81 | 95 | 90 | 145 | 201 |
MEDICAMEN BI INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,226 | 1,255 | 1,127 | 1,154 | 1,409 | |
Other income | Rs m | 37 | 19 | 8 | 17 | 25 | |
Total revenues | Rs m | 1,263 | 1,274 | 1,135 | 1,172 | 1,433 | |
Gross profit | Rs m | 175 | 195 | 197 | 241 | 243 | |
Depreciation | Rs m | 22 | 25 | 25 | 58 | 64 | |
Interest | Rs m | 14 | 9 | 15 | 19 | 34 | |
Profit before tax | Rs m | 175 | 180 | 164 | 181 | 170 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 55 | 47 | 43 | 32 | 23 | |
Profit after tax | Rs m | 120 | 133 | 121 | 149 | 147 | |
Gross profit margin | % | 14.2 | 15.5 | 17.5 | 20.9 | 17.3 | |
Effective tax rate | % | 31.4 | 26.1 | 26.0 | 17.7 | 13.6 | |
Net profit margin | % | 9.8 | 10.6 | 10.8 | 12.9 | 10.5 |
MEDICAMEN BI BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 962 | 1,041 | 960 | 1,230 | 1,634 | |
Current liabilities | Rs m | 485 | 565 | 533 | 727 | 826 | |
Net working cap to sales | % | 38.8 | 38.0 | 37.9 | 43.6 | 57.4 | |
Current ratio | x | 2.0 | 1.8 | 1.8 | 1.7 | 2.0 | |
Inventory Days | Days | 3 | 3 | 5 | 6 | 35 | |
Debtors Days | Days | 129,117,833 | 145,292,128 | 170,160,472 | 1,999 | 1,691 | |
Net fixed assets | Rs m | 400 | 751 | 913 | 944 | 1,062 | |
Share capital | Rs m | 117 | 122 | 122 | 122 | 127 | |
"Free" reserves | Rs m | 749 | 1,090 | 1,207 | 1,343 | 1,806 | |
Net worth | Rs m | 866 | 1,212 | 1,329 | 1,465 | 1,933 | |
Long term debt | Rs m | 0 | 24 | 64 | 51 | 9 | |
Total assets | Rs m | 1,366 | 1,813 | 1,940 | 2,252 | 2,766 | |
Interest coverage | x | 13.7 | 20.3 | 11.8 | 10.3 | 6.0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.7 | 0.6 | 0.5 | 0.5 | |
Return on assets | % | 9.8 | 7.8 | 7.0 | 7.5 | 6.6 | |
Return on equity | % | 13.9 | 11.0 | 9.1 | 10.2 | 7.6 | |
Return on capital | % | 21.8 | 15.3 | 12.9 | 13.2 | 10.5 | |
Exports to sales | % | 41.2 | 45.7 | 72.2 | 72.8 | 75.6 | |
Imports to sales | % | 5.3 | 4.8 | 1.5 | 5.3 | 6.3 | |
Exports (fob) | Rs m | 506 | 574 | 814 | 840 | 1,064 | |
Imports (cif) | Rs m | 65 | 61 | 17 | 61 | 89 | |
Fx inflow | Rs m | 506 | 574 | 814 | 840 | 1,064 | |
Fx outflow | Rs m | 71 | 63 | 30 | 88 | 136 | |
Net fx | Rs m | 434 | 511 | 784 | 751 | 928 |
MEDICAMEN BI CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 43 | 128 | 128 | 41 | -63 | |
From Investments | Rs m | -148 | -373 | -178 | -85 | -59 | |
From Financial Activity | Rs m | -37 | 191 | 58 | 43 | 291 | |
Net Cashflow | Rs m | -141 | -54 | 8 | -1 | 170 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Rahul Bishnoi | COMP SEC: Parul Choudhary | YEAR OF INC: 1993 | BSE CODE: 531146 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare MEDICAMEN BI With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.